已收盘 10-10 16:00:00 美东时间
-0.650
-2.37%
Bel Fuse Inc. plans to release preliminary third-quarter financial results after market close on October 29, 2025, followed by an earnings conference call on October 30, 2025, at 8:30 a.m. ET. Participants can join via phone (877.407.0784 or 201.689.8560 for international) or online at https://ir.belfuse.com/events-and-presentations. A replay will be available starting at 12:30 p.m. ET for 30 days.
10-09 12:00
BioLife Solutions, Inc. (NASDAQ:BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools for the cell and gene therapy ("CGT") market, announces the sale of SAVSU Cleo
10-07 20:10
BioLife Solutions ( ($BLFS) ) has issued an update. On August 20, 2025, BioLife...
08-22 04:48
HC Wainwright & Co. analyst Yi Chen maintains BioLife Solutions (NASDAQ:BLFS) with a Buy and raises the price target from $30 to $32.
08-08 18:38
BioLife Solutions (NASDAQ:BLFS) raises FY2025 sales outlook from $95.500 million-$99.000 million to $100.000 million-$103.000 million vs $97.747 million estimate.
08-08 04:13
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Niagen Bioscience (NASDAQ:NAGE) is preparing to release its quarterly earnings ...
08-06 02:04
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced that as part of a larger round of
07-28 20:07
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
06-28 07:00